SK
Sumit Kher
About Sumit Kher
Data last updated:
Sumit Kher is a Director at Nuberg Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Nuberg Pharmaceuticals Private Limited reported revenue of ₹3.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuberg Pharmaceuticals Private Limited U51909PB2017PTC047148 | Director | 07 Nov 2017 | 2017 | ₹3.17 Cr (FY 2025) | Active |
Board colleagues of Sumit Kher
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pardeep Malhotra | 07977064 | Nuberg Pharmaceuticals Private Limited | Director |
| Shifali Malhotra | 07977076 | Nuberg Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumit Kher
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumit Kher
Sumit Kher currently holds 1 directorship: Nuberg Pharmaceuticals Private Limited (Director, since 07 Nov 2017, revenue ₹3.17 Cr (FY 2025)).
Sumit Kher was first appointed on 07 Nov 2017 as Director at Nuberg Pharmaceuticals Private Limited.
The current boards of Sumit Kher's companies include Pardeep Malhotra (Nuberg Pharmaceuticals Private Limited), Shifali Malhotra (Nuberg Pharmaceuticals Private Limited).